These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 11984073

  • 1. Arsenic trioxide as a novel anticancer agent against human transitional carcinoma--characterizing its apoptotic pathway.
    Pu YS, Hour TC, Chen J, Huang CY, Guan JY, Lu SH.
    Anticancer Drugs; 2002 Mar; 13(3):293-300. PubMed ID: 11984073
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Docosahexaenoic acid enhances arsenic trioxide-mediated apoptosis in arsenic trioxide-resistant HL-60 cells.
    Sturlan S, Baumgartner M, Roth E, Bachleitner-Hofmann T.
    Blood; 2003 Jun 15; 101(12):4990-7. PubMed ID: 12609832
    [Abstract] [Full Text] [Related]

  • 4. Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.
    Lösler S, Schlief S, Kneifel C, Thiel E, Schrezenmeier H, Rojewski MT.
    Ann Hematol; 2009 Nov 15; 88(11):1047-58. PubMed ID: 19301004
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
    Cai X, Shen YL, Zhu Q, Jia PM, Yu Y, Zhou L, Huang Y, Zhang JW, Xiong SM, Chen SJ, Wang ZY, Chen Z, Chen GQ.
    Leukemia; 2000 Feb 15; 14(2):262-70. PubMed ID: 10673743
    [Abstract] [Full Text] [Related]

  • 7. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3.
    Hu XM, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2003 Jul 15; 52(1):47-58. PubMed ID: 12750841
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
    Zhu XH, Shen YL, Jing YK, Cai X, Jia PM, Huang Y, Tang W, Shi GY, Sun YP, Dai J, Wang ZY, Chen SJ, Zhang TD, Waxman S, Chen Z, Chen GQ.
    J Natl Cancer Inst; 1999 May 05; 91(9):772-8. PubMed ID: 10328107
    [Abstract] [Full Text] [Related]

  • 11. Induction of apoptosis in arsenic trioxide-treated lung cancer A549 cells by buthionine sulfoximine.
    Han YH, Kim SZ, Kim SH, Park WH.
    Mol Cells; 2008 Aug 31; 26(2):158-64. PubMed ID: 18596414
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis.
    Kitamura K, Minami Y, Yamamoto K, Akao Y, Kiyoi H, Saito H, Naoe T.
    Leukemia; 2000 Oct 31; 14(10):1743-50. PubMed ID: 11021749
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine.
    Maeda H, Hori S, Ohizumi H, Segawa T, Kakehi Y, Ogawa O, Kakizuka A.
    Cell Death Differ; 2004 Jul 31; 11(7):737-46. PubMed ID: 15002036
    [Abstract] [Full Text] [Related]

  • 18. Topoisomerase I-DNA complexes contribute to arsenic trioxide-induced apoptosis.
    Sordet O, Liao Z, Liu H, Antony S, Stevens EV, Kohlhagen G, Fu H, Pommier Y.
    J Biol Chem; 2004 Aug 06; 279(32):33968-75. PubMed ID: 15178684
    [Abstract] [Full Text] [Related]

  • 19. Involvement of mitochondrial aggregation in arsenic trioxide (As2O3)-induced apoptosis in human glioblastoma cells.
    Haga N, Fujita N, Tsuruo T.
    Cancer Sci; 2005 Nov 06; 96(11):825-33. PubMed ID: 16271077
    [Abstract] [Full Text] [Related]

  • 20. [Investigation of apoptosis mechanism of arsenic trioxide on oral squamous cell carcinoma].
    Guo J, Zhang ZY.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jan 06; 38(1):20-3. PubMed ID: 12760770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.